Hayat Jawadi, DO
Gynecology · Henderson, NVNPI 1821300716
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.8%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 83.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $888 and has fallen 98.4% since, to $15 in 2025.
Across 129 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Caldera Medical, Inc$140
- Merz North America, Inc.$89
- Pfizer$61
- Lupin Inc.$30
- BD$29
- plus $176 from 10 others
What the payments were for
- Speaking & faculty fees$1,59051%
- Food & beverage$1,52149%
- Education$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 108 | $2,606 |
| Caldera Medical, Inc | 1 | $140 |
| Merz North America, Inc. | 2 | $89 |
| Pfizer | 3 | $61 |
| Lupin Inc. | 2 | $30 |
| BD | 1 | $29 |
| Organon | 2 | $25 |
| Boston Scientific | 2 | $25 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Coopersurgical, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Duchesnay USA Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,130 in reported general payments places this provider in the 80th percentile of 30 gynecology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $3,108 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Henderson
- Duane AndersonLas Vegas$24K
- Randall JackReno$18K
- Yizhou ErnstReno$7K
- Barbara WotherspoonLas Vegas$5K
- Elizabeth HutsonSparks$5K
- Paul DaskalosNorth Las Vegas$3K
- Sherrie HaldReno$2K
- Maribel MonroeLas Vegas$2K
- Shana MilesNellis Afb$2K
- Staci PaulReno$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.